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ABSTRACT
Cochlear implant (CI) is a surgically implanted electronic device that provides a sense of sound to a person 
who is profoundly deaf. CI represents the current treatment for patients affected by profound sensorineu-
ral hearing loss (SNHL). At first times, only deaf adults were considered to be candidates for a CI; however, 
with the development of technology and gained experience by pshycians, indications for cochlear implan-
tation have been expanded. Today, CIs are implanted also in children and broader indications are followed. 
There are, however, a number of patients who are potential candidates for CI but do not completely fulfill the 
current indications. Residual hearing and duration of deafness represent prognostic indicators for CI per-
formance; however, prelingually deafened adults and children with residual hearing are still point at issue. 
Anatomical variations such as cochlear malformation, ossification and chronic otitis media still represent a 
contraindication to CI for some surgeons. Although the technology for cochlear implant surgery is advanc-
ing everyday, there may be several complications related to the device or operation and some of them can 
be healed only with medical therapy but some are serious enough to process to reimplantation. In this arti-
cle the indications and contraindications for cochlear implant candidates and complications that may occur 
during or after the operation were reviewed under the light of the literature.
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INTRODUCTION
Hearing loss is one of the most common health 
problems. Approximately 1-3 out of 1000 babies is 
born with a hearing loss (1). Lack of acoustic stimu-
li to the auditory system arising from sensorineural 
hearing loss has been usually coped with the incep-
tion of cochlear implantation in the 1980s (2). Co-
chlear implants (CI) can improve speech and sound 
perception, promote development of verbal language 
and auditory skills and educational development and 
also suppress tinnitus in some patients (2). Depend-
ing on the grade of hearing loss, affected individuals 
can be fitted successfully with hearing aids. For pa-
tients with hearing loss that is not relieved with hear-
ing aids, a cochlear implant may present an opportu-
nity for hearing.
The CI is a device which is surgically placed 
into the cochlea and converts sound to an electrical 
signal. This signal is conducted via electrodes to the 
spiral ganglion cells in the cochlea. As of 2012, an 
estimated 324,000 patients worldwide have CIs im-
planted (3). But, this number represents only a small 
number of individuals potentially benefitted from 
implantation. 
Although individual reactions to CIs depend 
on a number of psychosocial and physical factors, 
the new trend for improving performance with more 
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sophisticated hardware i.e. electrodes and program-
ming strategies has loosened the indications for co-
chlear implantation in recent years (3). Plenty of de-
vices are approved recently for use in patients with 
unilateral hearing loss rather then a bilateral pro-
found loss that was required prevoiusly (2). Addition-
ally, some studies have begun using shorter electrode 
arrays for shallow insertion in patients with substan-
tial low-frequency residual hearing. This technique 
will allow the recipient to continue to use amplified 
hearing aid for the low frequencies simultaneously 
with a CI for the high frequencies.
Complications are unavoidable with cochlear 
implantation as with all surgical procedures. They 
may be easy to treat like temporary vertigo or terrible 
enough like death due to meningitis. It is advisable 
that surgeons without prior experience should not 
perform an operation themselves; they should work 
with a more experienced surgeon when performing 
their first implant.
In this article, indications and related etiolog-
ic factors, contraindications and complications of co-
chlear implantatation were discussed according to 
the literature.
INDICATIONS OF COCHLEAR 
IMPLANTATION
From the first introduction of this device, FDA 
which has great influence on cochlear implantation 
candidacy has pursued several clinical trials on this 
issue. Many supplements about the technological im-
provements of the devices have been presented to the 
FDA. Therefore, implant candidacy is generally based 
on the best knowledge and the decision of the surgeon 
following the patient (2). Patients, child or adult, with 
severe-to-profound bilateral sensorineural hearing 
loss and some pathologies limited to the cochleae are 
potential applicants for cochlear implantation. There 
are some classical criteria for candidacy but chang-
es have firstly included implanting patients with in-
creasing degree of preoperative open-set speech skills, 
patients with increasing degree of residual hearing, 
patients, especially children at younger ages and with 
abnormal cochlea as much as possible (2).
The most widely used criteria for candidacy 
include bilateral severe-to-profound sensorineural 
hearing loss (SNHL), the optimal age should be be-
tween 12 months and 5 years but younger ages can 
also be the candidate, lack of improvement in hear-
ing and speech benefits from hearing aids after a 
3 months usage, the family of the patient will pro-
mote the surgery and postoperative rehabilitation, 
the family and the patients have convenient hope for 
the outcome of the surgery and are available for re-
habilitation and education and also there should be 
no contraindications for surgery (4). If the audimet-
ric candidacy is described distinctly, it ranges from 
severe to profound SNHL for ages from 2 to 17 years 
and profound SNHL for ages from 12 to 24 months, 
that is for children aged 12-24 months, the pure-tone 
average (PTA) should equal or exceed 90 dB (3). For 
patients older than 24 months, the PTA should equal 
or exceed 70 dB. If the patient can detect speech with 
best-fit hearing aids, a speech-recognition test in a 
sound field of 55 dB HL sound pressure level (SPL) is 
performed (3). A number of speech recognition tests 
are currently in use. Speech recognition criteria in-
clude limited benefit from binaural amplification tri-
al with word recognition tests like MLNT (Multisyl-
labic Lexical Neighborhood Test) and LNT (Lexical 
Neighborhood Test) scores ≤30% for 2-17 years and 
limited benefit from binaural amplification trial for 
12-24 months (2,3) (Table 1).
If the prelingual patient is at younger age when 
the implantation is performed, the outcome will be 
better. As a result, the patient will make full usage 
of the brain, auditory deprivation can be prevented, 
and speech and language abilities can be developed 
easily because the brain cannot lose its plasticity. Be-
fore implantation, children bigger than 6 years of age 
and adolescents should wear fitted hearing aids and 
have some auditory practice. Also they should be giv-
en language training while they are young (4).
For postlingual patients, some additional cri-
teria can be as postlingual deafness of all ages, no 
or little benefit from hearing aid amplification with 
preoperative scores for speech recognition test is low-
er than 50% in ear to be implanted and 60% bilateral-
ly in best-aided condition (2,4). Also, emotional and 
psychological stability with good motivation is im-
portant for candidacy. The language environment of 
the home and workplace after surgery affect the out-
come. Another affecting factor for the outcome is the 
onset age and duration of hearing loss. Generally, an 
early onset and a long duration of hearing loss have 
poorer outcomes for postlingual patients (4,5).
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In addition to these criterias, the indications 
have been loosened for candidacy because of some 
reasons mentioned above e.g. technological develop-
ments or influences by some health agencies. New 
concepts in the candidacy are dealing with the fol-
lowing topics; CI and hearing preservation, cochle-
ar implantation at younger ages, CI and relation with 
genetic hearing loss, CI for unilateral deafness and 
tinnitus, CI and neural plasticity and bilateral co-
chlear implantation (2,5). In the ongoing part of the 
article, some etiologic factors resulting in hearing 
loss related with the candidacy of cochlear implanta-
tion will be discussed.
ETIOLOGIES OF HEARING LOSS 




Hereditary hearing loss accounts for almost 
50% of all congenital sensorineural hearing loss, and 
it is caused by genetic mutations. It can be the re-
sult of a mutation in a single gene, or combination 
of mutations of different genes (6). Herediter hearing 
loss can either be non-syndromic, which is restrict-
ed to the inner ear, or syndromic and a part of mul-
tiple anomalies affecting the body. Non-syndrom-
ic HL can further be categorised by its mode of in-
heritance (6). Approximately 20% of non-syndrom-
ic sensorineural hearing loss (NSSHL) is inherited 
as autosomal dominant, which is also referred to as 
DFNA; this type of hearing loss is usually delayed 
onset. Eighty percent of inherited HL is autosomal 
recessive (DFNB), in which hearing loss is generally 
congenital, but some forms may emerge later in life. 
The inheritance of the remaining types of HL is ei-
ther mitochondrial or X-linked (DFN) (less than 1 
percent). To date, 125 deafness loci have been report-
ed in the literature; 58 DFNA loci, 63 DFNB loci and 
4 X-linked loci (7). 
The GJB2 gene encodes for the protein Connex-
in 26 (Cx26) and the most common cause of nonsyn-
dromic autosomal recessive deafness is mutation in 
Cx26, which is responsible for approximately 20% of 
hereditary hearing loss in children (8). Connexins are 
transmembrane proteins forming gap-junction chan-
nels which allow cell-to-cell communication and 
ion transport. Some examples of syndromic hearing 
loss are Waardenburg, Stickler, Brachio-oto-renal, 
Treacher Collins, Neurofibromatosis, Usher, Jervell 
Lange-Neilsen, Alport, and Pendred syndromes (8).
Infectious
About the nonmeningitis causes, the most com-
mon environmental cause of hearing impairment in 
children is congenital Cytomegalovirus (CMV) (9). 
Twenty five to thirty three percent of childhood deaf-
Indications of the Cochlear Implantation
Audimetric candidacy 
   12-24 months 2-17 years >18 years
Profound SNHL - PTA ≥90 dB Severe to profound SNHL- PTA ≥70 dB Severe to profound SNHL- PTA ≥70 dB
Speech recognition tests
   12-24 months 2-17 years >18 years
Limited benefit from binaural 
amplification
Limited benefit from binaural amplifi-
cation with scores ≤30% 
Limited benefit from binaural amplifica-
tion with scores lower than 50% in ear to 




New concepts in indications
   Younger age, Hearing preservation, Unilateral deafness, Tinnitus, Bilateral implantation
Table 1. Indications for patients related with cochlear implant candidacy (SNHL – sensorineural hearing loss, PTA – 
pure-tone average)
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ness can be generated by non-genetic or environmen-
tal causes. Asymptomatic congenital CMV infections 
can be a cause of mild to profound sensorineural hear-
ing loss in 10-15% of patients (9). Rubella, toxoplasmo-
sis, syphilis, measles and mumps are some of the other 
potential infectious agents causing hearing loss.
Auditory neuropathy/dyssynchrony
Auditory neuropathy is a kind of hearing loss in 
which the outer hair cells are present and functional, 
but sound can not be transmitted truly to the audito-
ry nerve and brain. It is also known as auditory neu-
ropathy/auditory dyssynchrony or auditory neurop-
athy spectrum disorder and implicates the vestibulo-
cochlear nerve as the site of pathology (10). Otoacous-
tic emissions, the cochlear microphonic of electroco-
chleography or pure-tone audiometry can be used to 
assess outer hair cell function. A defect in spiral gan-
glion cells, inner hair cells or the synapse between 
the two can be the cause of this disorder (10).
Auditory neuropathy is seen in both children 
and adults. Normal to profound hearing loss can 
be obtained on pure-tone audiometry, but especial-
ly speech discrimination testing with poor perfor-
mance is the common criteria in patients with au-
ditory neuropathy (10). The most potent risk factors 
are anoxia, hyperbilirubinemia, and prematurity for 
auditory neuropathy spectrum. In several studies it 
was reported that patients had some forms of hered-
itary nonsyndromic autosomal dominant auditory 
neuropathy progressing to outer hair cell malfunc-
tion causing decline in pure-tone audiometer results. 
Some of the patients in these series benefitted from 
hearing aids or FM devices but in some a CI  is the 
only way to communicate (10-12).
Hyperbilirubinemia
In the neonatal jaundice, bilirubin may pass the 
blood-brain barrier and be deposited in the ventral 
cochlear nucleus and can cause sensorineural hear-
ing loss. On the ABR test, transient loss of wave IV 
and V is seen in 1 to 3 of newborns with bilirubin 
levels of 15-25 mg/dL. Higher concentrations of bili-
rubin in the blood are also a risk factor for auditory 
neuropathy (13).
B-Perlingual and/or Postlingual Causes
Infectious
One of the infectious causes for hearing loss is 
meningitis. The most common organisms causing 
meningitis include Haemophilus influenzae, Strepto-
coccus pneumoniae and  Neisseria meningitidis. Ap-
proximately 9% of childhood deafness can be caused 
by meningitis (14). The highest incidence of organ-
isms that cause hearing loss has S. pneumoniae with 
31% (14). If S. pneumoniae is the causative organism 
for hearing loss, patients are developing obstruction 
of the cochlear lumen ie labyrinthitis ossificans and 
it makes CI surgery difficult (14,15).
Ototoxicity
Plenty of medications can cause hearing loss 
and the most well known ototoxic medication are 
aminoglycoside antibiotics (16). Other commonly 
known ototoxic medications include salicylates, loop 
diuretics, erythromycin, vancomycin, quinine and 
cisplatin. Because of severe to profound sensorineu-
ral hearing loss after ototoxicity, CI is a good treat-
ment option. 
Trauma
After temporal bone trauma, conductive hear-
ing loss most commonly happens because of tym-
panic membrane perforation, ossicular displace-
ment or hemotympanum. The otic capsule is more 
resistant to trauma but sometimes breaks may in-
volve the labyrinth or/and cochlea. If a fracture pass-
es from the otic capsule, it almost always results in 
severe-to-profound sensorineural hearing loss. It is 
very uncommon to see bilateral otic capsule frac-
tures but it would be an indication for cochlear im-
plantation (17). After the fracture of the otic capsule, 
there would be intraluminal ossification or fibrosis 
which can make electrode insertion much more dif-
ficult. There should be preoperative imaging before 
surgery for providing additional information about 
fibrosis or ossification.
Noise-induced hearing loss
According to the World Health Organization 
(WHO), the number of people affected worldwide 
by hearing loss increased from 120 million to 250 
million worldwide from 1995 to 2004 (18). Much of 
this impairment (16%) may be caused by exposure to 
noise on the job (18). Noise induced hearing loss can 
be temporary or permanent. Acoustic trauma occurs 
after exposure to sounds louder than 140 dB, such as 
sounds of gunshots or explosions. Outer hair cells are 
the most susceptible to noise exposure. After expo-
sure to noise, the outer hair cells swell typically but if 
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the noise exposure ceases, they may normalize. Most 
commonly a notch at 4000 Hz on pure-tone audiom-
etry can be seen in the setting of hearing loss sec-
ondary to noise exposure, but hearing loss may ad-
vance to a degree and amplification can not provide 
good benefit then cochlear implantation may be con-
sidered (3).
Tinnitus
Tinnitus refers to abnormal perception of sound 
although there is actually no sound and it currently 
affects nearly 10% of the population (19). When tin-
nitus starts to reduce the quality of life, patients want 
to be cured and look for appropriate treatment. For 
patients experiencing severe tinnitus, tinnitus re-
training therapy (TRT) is one of the proven treat-
ment options. Because of its expense, limited num-
ber of programs, and duration of therapy, a signif-
icant number of patients with severe tinnitus leave 
TRT and remain without treatment (19).
In some studies it was reported that some pa-
tients with preoperative tinnitus which were  CI re-
cipients had informed either abolition or reduction of 
their tinnitus when they wore their CI (20, 21). In a 
recent study, patients with single-sided deafness were 
implanted for severe tinnitus and in 20 out of 21, tin-
nitus was reduced or ceased significantly. Three of the 
patients in this study even displayed constant resid-
ual inhibition while not wearing their processor. Up 
to date for severe tinnitus, cochlear implantation may 
be one of the most successful treatment options (20).
Ménière disease
Meniere disease is characterized by room spin-
ning vertigo, aural fullness, tinnitus and fluctuat-
ing hearing loss. The diagnosis of this diease is made 
with a whole history and complete examination of 
the head and neck region, as well as imaging modal-
ities to rule out retrocochlear pathology. Exact di-
agnosis can be made by examination of histology of 
temporal bones in subjects with Meniere disease and 
it reveals the dilation of the endolymphatic compart-
ment. It is not clear whether endolymphatic hydrops 
is the final result of some other pathologic processes 
causing symptoms of Meniere or is the main reason 
for the symptoms.
House et al reported that in their study sample, 
in 11% of patients, Meniere’s disease was bilateral at 
presentation and meanwhile an additional 12% (14% 
of unilaterals) became bilateral during the follow-up 
period (22). It is difficult to predict progression of 
hearing loss in Meniere but severe to profound sen-
sorineural hearing loss may be a result. Recent stud-
ies on patients with Ménière disease underwent CI 
had overall better performance (23,24).
Presbyacusis
With aging, hearing loss initially begins with 
high frequencies, than progresses to lower frequen-
cies. Thirty to thirty five percent of 65 year olds have 
some hearing loss; this percentage rises to 40-50% for 
people over 70 years (25). Men are more commonly 
affected from presbycusis. Conventional hearing aids 
often supply benefit for patients, but only 20% wear 
this device. Patients with profound hearing loss who 
are unable to take advantage of traditional amplifica-
tion may utilize from a CI (26). Sometimes some pa-
tients have residual low frequency hearing, and they 
may use hearing aid/CI combination providing both 
electrical and acoustic stimulation (27).
CONTRAINDICATIONS
Contraindications to cochlear implantation 
may include deafness because of lesions of eight cra-
nial nevre or brain stem. They can be analyzed in 
two ways; relative and absolute. The absence of co-
chlear development demonstrated on CT and MRI 
as in Micheal deformity and cochlear atresia and lack 
of auditory nevre are some of the absolute contrain-
dications. Several other absolute contraindications 
may be severe mental disease, severe mental retarda-
tion to cooperate with speech training and acute or 
chronic otitis media and mastoiditis without eradi-
cation of the disease (2-4,6). Certain medical condi-
tions like pulmonary, cardiac and hematologic con-
ditions, uncontrolled epilepsy and not being avail-
able for rehabilitation remain relative contraindica-
tions. But secretory otitis media is not a surgical con-
traindication for cochlear implantation (Table 2). 
Single-stage or more than one-staged surgery 
can be applied in chronic otitis media with tym-
panic membrane perforation (4). In single-stage sur-
gery, any disease within the middle ear and mastoid 
cavity is eliminated by performing a myringoplasty 
and then the cochlear implantation is performed in 
the same procedure. More than one-staged surgery 
means firstly eliminating any disease, performing a 
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myringoplasty or tympanoplasty and then perform-
ing the cochlear implantation 3–6 months later (4,5).
COMPLICATIONS OF THE SURGERY
Complications of cochlear implantation are in a 
wide spectrum from temporary vertigo to death due 
to meningitis and related with medical, surgery or 
device problems (28). In literature, several forms of 
complication classification have been reported.
Kempf et al. classified the complications as 
early and late (29). They named the complications 
emerging in one week to 3 months – early compli-
cations and after 3 months – late (29). The complica-
tions of cochlear implantation were classified as ma-
jor and minor by Summerfield and Marschall (Table 
3) and they argued that minor complications can be 
healed with medical therapy without hospitalization 
but major complications may need hospitalization, 
revision surgery or reimplantation (30,31).
Infections are the most common complications 
of the cochlear implantation. The frequency is be-
tween 7-16.6% (32). The most common causative or-
ganism in simple skin and wound infections is Staph-
ylococcus aureus. It can be cured with oral antibiotic 
treatment without any need for hospitalization. Peri-
operative antibiotic prophylaxis may decrease the in-
fection rates significantly.
Skin flap infections course is more serious and 
may need reimplantation. Hematoma may be a pre-
disposing factor (33). Little insicions rather than big-
ger ones have decreased the insidence of all type of 
infections.
Pseudomonas infections can cause resistant in-
fections around the implant and the possible rea-
son for resistance is biofilm layer which decreased 
the penetrance of antibiotics and makes a barrier to 
immune mechanisms. Despite prolonged antibiotic 
therapy, reimplantation may be required (34).
Cholesteatoma is one of the late complications 
of cochlear implantation. During surgery, attention 
should be paid to protect the external auditory canal 
and especially bony tympanic annulus. Patients with 
persistant otorrhea after surgery should arouse sus-
picion for cholesteatoma (35).
Perilymph gusher can be seen during surgery 
as one of the intraoperative complications. It shows 
itself with leakage of cerebrospinal fluid to surgical 
field during cochleostomy. It is commonly seen in 
children with cochlear anomaly.
Facial nerve damage is rare. Intraoperative 
monitorization helps to protect the nerve. If not 
treated carefully, burr shaft can damage the nerve 
and temporary facial paresis occurs. Also chorda 
tympani can be damaged during surgery and deteri-
oration may be observed in the sense of taste. There-
fore, surgery must be performed with the rich irriga-
tion (36).
Magnet or receiver may be dislodged secondary 
to minor head traumas. But also allergic reactions, 
new bone formation or infections may be the causes 
of displacement. According to some authors, placing 
the implant into the bone socket properly and sutu-
ration to the neighboring tissues can prevent the dis-
lodging (37).
Because of some complications, reimplantation 
surgery should be performed (32). These are:
❖❖ Serious skin infection
❖❖ Device failure
❖❖ Serious device failure
Contraendications for the Cochlear Implantation
Absolute Relative
Agenesia of Cochlea Inappropiate medical conditions (e.g. pulmonary,  cardiac, hematologic) 
Agenesia of Cochlear Nerve Uncontrolled epilepsy
Severe mental disease Not being available for postoperative rehabilitation
Acute/chronic otitis media and mastoiditis without 
eradication of the disease
Mental retardation to cooperate with speech training
Table 2. Contraindications for the cochlear implant
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❖❖ Mild device failure
And some complications may need revision 
surgery but no need for reimplantation (32);
❖❖ Skin infection (for drainage or debridement)
❖❖ Cholesteatoma
❖❖ Displacement of the magnet
❖❖ Displacement of the receiver
❖❖ Displacement of the electrote or early recogni-
tion of wrong placement.
CONCLUSION
The purpose of this review article was to pro-
vide an overwiev on the etiologies of hearing loss cir-
cumvented with cochlear implantation and to pro-
vide a discussion on indications, contraindications 
and complications of CIs. A great number of chang-
es occur and indications are loosened for candida-
cy for cochlear implantation. Generally, accompany-
ing and satisfactory changes in surgical techniques 
have also been accompanied by. Together, this has 
improved the benefit and safety of cochlear implan-
tation. Indications for, and the advances in design of 
cochlear implantation have been paired by improve-
ments in surgical practices and decrease in compli-
cations. The improvements in safety and influences 
have further encouraged the use of these devices. To 
reduce the surgery-related complications, the patient 
should be carefully assessed preoperatively and sur-
geons without prior experience should not perform 
an operation themselves; they should work with a 
more experienced surgeon when performing their 
first implantation.
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